Salesforce's AI Push Faces Growth Skepticism Despite Strong Metrics

What happened

Salesforce is aggressively promoting its Agentic AI initiatives, with recent coverage highlighting Agentforce and Data Cloud as drivers of surging revenues and bookings, suggesting a potential growth turnaround. However, the stock has declined 30% over the past year, reflecting deep investor skepticism about whether AI can offset seat compression and reaccelerate broader demand, despite Agentforce ARR reaching ~$800M and CRPO growing 16% year-over-year. The company faces significant headwinds from weaker segments like Marketing & Commerce and ongoing concerns that AI usage may not translate into higher per-customer spend, as organic CRPO growth remains around 9%. Management is countering with aggressive capital returns, including a $25B accelerated share repurchase announced in March 2026, to bolster per-share value while navigating these challenges. Ultimately, the investment thesis centers on whether Agentforce usage metrics, such as Agentic Work Units, can sustain compounding growth and lift overall backlog in the coming quarters.

Implication

The key implication is that Salesforce's stock performance hinges on proving that agentic AI expands software budgets rather than compresses seat-based SaaS economics, requiring sustained scaling of Agentforce metrics like ARR and AWUs. Investors should watch for management's transparency in reporting these KPIs, as any reduction could signal underlying weakness and increase risk premiums. Additionally, the aggressive buyback program provides near-term support but masks fundamental growth concerns if AI adoption stalls or fails to improve broader backlog quality. Critical checkpoints include the next earnings report, which must show Agentforce usage growth above 30% quarterly and organic CRPO acceleration above 9% to justify a re-rating. Failure to meet these benchmarks could trigger further downside, emphasizing the need for a disciplined, evidence-based approach to position sizing.

Thesis delta

The new article reinforces the optimistic narrative around Salesforce's AI push but does not introduce new data that materially shifts the investment thesis from the DeepValue report. It echoes the need for proof that Agentforce and Data Cloud can drive reacceleration, but the core thesis remains unchanged: outperformance depends on upcoming quarterly validation of usage scaling and backlog growth. Investors should remain focused on concrete metrics rather than promotional commentary, as the stock's valuation already reflects skepticism about near-term execution.